In 2023, AI has progressed in drug discovery and has made treatment repurposing possible.
AI also provides the opportunity to save time in many different ways. In 2023, AI has progressed in drug discovery and has made treatment repurposing possible. Panna Sharma, CEO of Lantern Pharma, points to disease-specific AI discovery and development platforms as the next step. He compares this approach to using a laser on a specific target instead of a scattergun approach we are currently using. This hypothesis relies on efficient use of the immense amount of data biotech companies are sitting on: “The key is data readiness, or the transformation of this raw information into machine-learning friendly formats that can be harnessed by powerful AI algorithms. This readiness can allow AI to unlock the insight within the data, leading to groundbreaking clinical trials and accelerated drug development,” he said.